Pharma Pulse 7/29/24: Fighting the Drop in Vaccination Rates, OpenAI Takes Aim at Google & more

Fighting the Drop in Vaccination Rates

An unexpected consequence of the COVID 19 pandemic has been a loss in trust of vaccines. Over the past three flu seasons, there has been a drop in vaccination rates that is alarming experts. Dr. Gregg Sylvester, chief health officer at CSL Seqirus, spoke with Pharmaceutical Executive about the causes of the decline and how important it is to get the rates back to normal.

Drugflation Is Soaring, But It Can Be Tamed

Unbridled drugflation, or a point-in-time measure of the rising cost of pharmacy benefits, is taking its toll on corporate bottom lines and household budgets.

OpenAI Is Launching Search Engine, Taking Direct Aim at Google

Built with input from publishers, SearchGPT will summarize real-time information on websites.

Merck Receives Positive EU CHMP Opinion for KEYTRUDA®

Merck announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with Padcev (enfortumab vedotin-ejfv), an antibody-drug conjugate, for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma.

Applied Clinical Trials Magazine on LinkedIn

📹 In part 4 of this video interview, Carie Pierce, SVP, global head of growth & business development, DIA discusses how the organization is looking to expand into different global regions and continue leading awareness for the #clinicalresearch industry

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs